Business
American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024
NEWPORT BEACH, Calif., March 14, 2025--American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported preliminary, financial results for the fourth quarter and full year ended December 31, 2024. The results reported herein are preliminary. Final results will appear in the company’s 10-K for the fisca
About this update from American Vanguard Corporation
[{"type":"text","content":"Achieved Full-Year Adjusted EBITDA In-Line with Target Range","length":60,"tagName":"p","attribs":{}},{"type":"text","content":"Reduced Inventory by $47 million and reduced Debt by $22 Million in Fourth Quarter","length":82,"tagName":"p","attribs":{}},{"type":"text","content":"2025 Revenue and Adj. EBITDA Target Range of $565-$585 Million and $45-$52 Million","length":82,"tagName":"p","attribs":{}},{"type":"text","content":"NEWPORT BEACH, Calif., March 14, 2025--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported preliminary, financial results for the fourth quarter and full year ended December 31, 2024. The results reported herein are preliminary. Final results will appear in the company’s 10-K for the fiscal year ended December 31, 2024.","length":548,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2024 Preliminary Financial and Operational Highlights – versus Fourth Quarter 2023:","length":98,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales of approximately $169 million v. $172 million in the fourth quarter of 2023;","length":86,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA1 of approximately $18 million v. $22 million in 2023;","length":69,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Decreased debt by $22 million from $179 million that we reported as of September 30, 2024","length":89,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":244,"olType":false},{"type":"text","content":"Fiscal 2024 Full Year Preliminary Financial Highlights – versus Fiscal 2023 Full Year:","length":86,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales of approximately $550 million ($563 million when excluding Dacthal product recall impact) v. $579 million in 2023;","length":124,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Adjusted EBITDA of approximately $42 million v. $53 million in 2023;","length":68,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Approximately $118 million in non-recurring cash and non-cash charges in 2024 as management repo...